1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Next-Generation Non-Surgical Neurotechnology (N3) is a grant from DARPA's Biological Technologies Office that funds research to design, build, and validate a nonsurgical neural interface system. The program seeks to develop technology enabling neural recording and stimulation with sub-millimeter spatial resolution, primarily to expand the practical use of neural interfaces for able-bodied warfighters.
Up to 20 awards are anticipated through cooperative agreements and other procurement contracts. Eligible applicants are unrestricted — any type of entity including large corporations, universities, and small businesses may apply. Historically, DARPA has funded multidisciplinary teams led by large contractors, universities, and small businesses working at the frontier of neuroscience and engineering.
Get alerted about grants like this
Save a search for “DARPA - Biological Technologies Office” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar Next-Generation Non-Surgical Neurotechnology (N3) DARPA - Biological Technologies Office Document Type:Grants Notice Funding Opportunity Number:HR001118S0029 Funding Opportunity Title:Next-Generation Non-Surgical Neurotechnology (N3) Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Other Procurement Contract Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards:20 Assistance Listings:12.
910 -- Research and Technology Development Cost Sharing or Matching Requirement:No Original Closing Date for Applications:Jun 05, 2018 4:00 PM ET Current Closing Date for Applications:Jun 05, 2018 4:00 PM ET Archive Date:Jul 05, 2018 Estimated Total Program Funding: Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" Additional Information on Eligibility: ## Additional Information Agency Name:DARPA - Biological Technologies Office Description:DARPA seeks proposals to design, build, demonstrate, and validate a nonsurgical neural interface system to broaden the applicability of neural interfaces to the able-bodied warfighter.
The final technology aims to enable neural recording and stimulation with sub-millimeter spatial resolution. See attached BAA package for full details. Link to Additional Information:Fed Biz Ops Link Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes.
To continue working, click on the "OK" button below. This is being done to protect your privacy. Unsaved changes will be lost.
Based on current listing details, eligibility includes: Organizations leading multidisciplinary teams. Historically, DARPA has funded large corporations, universities, and small businesses. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
The OCRP Outcomes Consortium Development Award supports a multi-institutional research effort conducted by leading ovarian cancer researchers and consumer advocates that specifically focuses on identifying and understanding predictors of disease outcomes in ovarian cancer patients. This effort will be executed through a two-stage approach using two separate award mechanisms: this FY12 Outcomes Consortium Development Award, which will enable the consortium to lay the groundwork for the research project, including proof of concept, and the FY14 Outcomes Consortium Award, which will support the execution of the full research project. Funding Opportunity Number: W81XWH-12-OCRP-OCDA. Assistance Listing: 12.420. Funding Instrument: CA,G. Category: ST. Award Amount: $1.3M total program funding.
SBIR/STTR Programs is sponsored by Defense Health Agency (DHA). The DHA SBIR and STTR programs support U.S. small businesses in developing high-risk, high-impact medical materiel technologies with potential for wider commercialization, including those that could leverage AI for warfighter health and survival. This program seeks proposals that demonstrate both technical innovation and real clinical relevance in areas such as trauma care, battlefield triage, far-forward telemedicine, and digital health systems with AI-enabled triage.
Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Program is sponsored by Defense Health Agency (DHA). The DHA SBIR program provides funding and support for small businesses to develop innovative healthcare technologies and solutions that benefit the military. It focuses on biomedical and health-focused technologies that enhance medical readiness, clinical care delivery, force health protection, operational medicine, and military healthcare modernization. Topics are aligned with real-world needs such as trauma care, telemedicine, infectious disease diagnostics, and wearable monitoring tools.